PD-1 Inhibitor Improves Outcomes in NHL Subtype PD-1 Inhibitor Improves Outcomes in NHL Subtype

Treatment with the PD-1 inhibitor toripalimab plus radiation therapy improved outcomes in patients with a subtype of non-Hodgkin lymphoma, new data show.MDedge News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news